Motley Fool Podcasts

The big three healthcare companies aren’t paying much attention to Mark Cuban’s new health care venture, Cost Plus Drugs. But their margins could mean a huge opportunity for the new start-up. Chris Hill caught up with Cuban to discuss:
- Why he’s able to sell a leukemia drug for thousands of dollars less than competitors - Stocks he bought during the pandemic - Advice for potential NFL owner Jeff Bezos
To check out Mark's new business go to www.CostPlusDrugs.com
Companies mentioned: WBA, CVS, NFLX, LYV, LVS, AMZN
Host: Chris Hill Guest: Mark Cuban Producer: Ricky Mulvey Engineers: Dan Boyd, Austin Morgan, Tim Sparks
Learn more about your ad choices. Visit megaphone.fm/adchoices